Stocktoria
Minerva Neurosciences, Inc. NERV
Minerva Neurosciences, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | $41.2M | $0 | $0 | $0 | — |
| R&D expense | $5.8M | $11.9M | $12.7M | $14.6M | $32.0M | $22.0M | $58.1M | $34.9M | $30.3M | $20.4M |
| Operating income | -$15.1M | -$21.8M | -$23.1M | -$25.2M | -$45.4M | $1.8M | -$75.9M | -$51.7M | -$41.2M | -$30.2M |
| Income tax | — | — | — | — | -$1.8M | — | -$2.3M | $0 | -$9.4M | $0 |
| Net income | -$293.4M | $1.4M | -$30.0M | -$32.1M | -$49.9M | $1.9M | -$72.2M | -$50.2M | -$31.5M | -$31.0M |
| EPS (diluted) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.35 | $0.05 | $-1.85 | — | — | — |
| Operating cash flow | -$13.5M | -$19.6M | -$14.8M | -$24.6M | -$24.6M | -$33.8M | -$43.4M | -$41.9M | $3.1M | -$25.7M |
| Free cash flow | — | — | — | -$24.7M | — | — | — | — | $3.0M | — |
| Cash & equivalents | $82.3M | $21.4M | $40.9M | $36.1M | $60.8M | $25.4M | $21.4M | $50.2M | $26.1M | $83.0M |
| Total assets | $98.0M | $37.1M | $56.9M | $55.1M | $77.1M | $57.6M | $77.5M | $139.1M | $183.7M | $132.9M |
| Total liabilities | $233.8M | $62.8M | $85.4M | $75.1M | $69.1M | $5.0M | $49.7M | $48.9M | $52.1M | $27.0M |
| Shareholders' equity | -$140.7M | -$25.7M | -$28.5M | -$20.0M | $8.0M | $52.7M | $27.8M | $90.3M | $131.6M | $106.0M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | -100.0% | — | — | — | — | — |
| Net income growth | -20492.7% | — | — | — | -2671.4% | — | — | — | — | — |
| EPS growth | -18347.4% | — | — | — | -18800.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.